MyAverix Finance
STU · Healthcare
ENZON PHARM (EZ1.SG) (EZ1)
Biotechnology
ENZON PHARM (EZ1.SG) (EZ1) is listed on STU in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for EZ1
ENZON PHARM (EZ1.SG) (EZ1) — FAQ
What is EZ1's P/E ratio?
The price-to-earnings (P/E) ratio for ENZON PHARM (EZ1.SG) (EZ1) is 25.00 (data as of 2026-05-23).
Does ENZON PHARM (EZ1.SG) pay a dividend?
Dividend yield is not available in the current snapshot for ENZON PHARM (EZ1.SG) (EZ1). Check the MyAverix Finance app for the latest dividend data.
What sector is ENZON PHARM (EZ1.SG) in?
ENZON PHARM (EZ1.SG) (EZ1) is classified in the Healthcare sector (Biotechnology industry).
What exchange is EZ1 listed on?
EZ1 is listed on STU.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.